Interestingly, many PD patients with LRRK2 (G2019S) mutations exhibit α-synuclein-positive LBs9,16,17, even though nearly half the LRRK2 (G2019S)-PD cases are LB-negative18,19. This evidence concerns the gene LRRK2 and Parkinson disease.